Investigational New Drug Applications; Proposed Amendment to Clinical Hold Regulations for Products Intended for Life- Threatening Diseases
Federal Register 1997 September 24; 62(185): 49946-49954
Permanent LinkFind in a Library
Showing items related by title, author, creator and subject.
Guidance for Industry: Information Program on Clinical Trials for Serious or Life-Threatening Diseases and Conditions Unknown author (United States. Food and Drug Administration [FDA]. Center for Drug Evaluation and Research [CDER], 2002-03)